ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 191 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $92,660,000 | +90.0% | 2,000,000 | 0.0% | 3.20% | +51.9% |
| Q1 2019 | $48,760,000 | +55.4% | 2,000,000 | +4.0% | 2.11% | +40.7% |
| Q1 2018 | $31,378,000 | -55.3% | 1,922,655 | -65.3% | 1.50% | -67.1% |
| Q4 2017 | $70,207,000 | +4.3% | 5,543,029 | -5.3% | 4.55% | -12.9% |
| Q3 2017 | $67,342,000 | +89.5% | 5,853,029 | +25.2% | 5.22% | +16.4% |
| Q2 2017 | $35,535,000 | +4.0% | 4,675,376 | +0.7% | 4.49% | +2.7% |
| Q1 2017 | $34,183,000 | +2331.2% | 4,641,400 | +2800.9% | 4.37% | +1437.7% |
| Q4 2016 | $1,406,000 | – | 160,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |